$10.13
-0.28-2.64%
In chiusura: -
Santen Pharmaceutical segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Santen Pharmaceutical utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
SNPHY | Santen Pharmaceutical | $0.24 | — | — | — | $493.21M | — | — | — | 11/06/2025 | |
SNPHY | Santen Pharmaceutical | $0.22 | — | — | — | $479.81M | — | — | — | 08/26/2025 | |
SNPHY | Santen Pharmaceutical | $0.16 | — | $0.05 | — | $533.27M | — | $506.40M | — | 05/13/2025 | |
SNPHY | Santen Pharmaceutical | $0.25 | — | $0.20 | — | $521.40M | — | $501.44M | — | 02/06/2025 | |
SNPHY | Santen Pharmaceutical | $0.25 | — | $0.24 | — | $508.12M | — | $493.21M | — | 11/07/2024 | |
SNPHY | Santen Pharmaceutical | $0.25 | — | $0.22 | — | $527.72M | — | $479.81M | — | 08/06/2024 | |
SNPHY | Santen Pharmaceutical | $0.24 | — | $0.16 | — | $599.14M | — | $533.27M | — | 05/09/2024 | |
SNPHY | Santen Pharmaceutical | $0.13 | — | $0.25 | — | $474.84M | — | $521.40M | — | 02/13/2024 | |
SNPHY | Santen Pharmaceutical | $0.09 | — | $0.25 | — | $458.96M | — | $508.12M | — | 11/07/2023 | |
SNPHY | Santen Pharmaceutical | $0.15 | — | $0.25 | — | $505.98M | — | $527.72M | — | 08/03/2023 | |
SNPHY | Santen Pharmaceutical | $0.20 | — | $0.24 | — | $596.81M | — | $599.14M | — | 05/11/2023 | |
SNPHY | Santen Pharmaceutical | $0.16 | — | $0.13 | — | $602.68M | — | $474.84M | — | 02/07/2023 | |
SNPHY | Santen Pharmaceutical | $0.22 | — | $0.09 | — | $580.33M | — | $458.96M | — | 11/08/2022 | |
SNPHY | Santen Pharmaceutical | $0.21 | — | $0.15 | — | $591.80M | — | $505.98M | — | 08/04/2022 | |
SNPHY | Santen Pharmaceutical | $0.20 | — | $0.20 | — | $537.92M | — | $596.81M | — | 05/10/2022 | |
SNPHY | Santen Pharmaceutical | $0.20 | — | $0.16 | — | $608.18M | — | $602.68M | — | 02/10/2022 | |
SNPHY | Santen Pharmaceutical | $0.25 | — | $0.22 | — | $576.62M | — | $580.33M | — | 11/10/2021 | |
SNPHY | Santen Pharmaceutical | $0.21 | — | $0.21 | — | $535.34M | — | $591.80M | — | 08/06/2021 | |
SNPHY | Santen Pharmaceutical | $0.20 | — | $0.20 | — | $543.13M | — | $537.92M | — | 05/11/2021 | |
SNPHY | Santen Pharmaceutical | $0.19 | — | $0.20 | — | $584.67M | — | $608.18M | — | 02/04/2021 | |
SNPHY | Santen Pharmaceutical | $0.21 | — | $0.25 | — | $576.20M | — | $576.62M | — | 11/06/2020 |
Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
---|---|---|---|---|
Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
---|---|---|---|---|
Si prevede che Santen Pharmaceutical (SNPHY) fornisca risultati il novembre 6, 2025. Gli ultimi risultati sono stati pubblicati il maggio 13, 2025 per il Q4.
L'EPS effettivo era $0.05, che superato la stima di $0.00.
Le entrate effettive sono state $506.4M, che superato la stima di $0K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.